CIK 0000914475
- Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330525145
- Phone
- +1 858-617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-08 | BENEVICH ERIC Chief Commercial Officer | Sale | −980 | $79.67 | $78K | 20,338 |
| 2022-02-08 | ABERNETHY MATT Chief Financial Officer | Sale | −980 | $79.65 | $78K | 20,204 |
| 2022-02-07 | Boyer David W. Chief Corp. Affairs Officer | Sale | −240 | $81.07 | $19K | 2,291 |
| 2022-02-07 | ROBERTS EIRY Chief Medical Officer | Sale | −1,623 | $80.77 | $131K | 22,741 |
| 2022-02-07 | ROBERTS EIRY Chief Medical Officer | Sale | −1,121 | $80.80 | $91K | 23,746 |
| 2022-02-07 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −865 | $80.78 | $70K | 16,474 |
| 2022-02-07 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −1,015 | $80.73 | $82K | 17,387 |
| 2022-02-07 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −801 | $80.65 | $65K | 18,104 |
| 2022-02-07 | Lippoldt Darin Chief Legal Officer | Sale | −605 | $80.54 | $49K | 34,993 |
| 2022-02-07 | Lippoldt Darin Chief Legal Officer | Sale | −1,522 | $80.78 | $123K | 36,363 |
| 2022-02-07 | Lippoldt Darin Chief Legal Officer | Sale | −1,041 | $80.74 | $84K | 37,296 |
| 2022-02-07 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale | −2,422 | $80.83 | $196K | 455,150 |
| 2022-02-07 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale | −3,248 | $80.82 | $263K | 458,071 |
| 2022-02-07 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale | −3,040 | $80.80 | $246K | 460,801 |
| 2022-02-07 | Gano Kyle Chief Business Development Off | Sale | −703 | $80.68 | $57K | 105,619 |
| 2022-02-07 | Gano Kyle Chief Business Development Off | Sale | −1,974 | $80.80 | $159K | 107,395 |
| 2022-02-07 | Gano Kyle Chief Business Development Off | Sale | −1,623 | $80.78 | $131K | 108,857 |
| 2022-02-07 | Gano Kyle Chief Business Development Off | Sale | −1,600 | $80.77 | $129K | 110,294 |
| 2022-02-07 | Cooke Julie Chief Human Resources Officer | Sale | −605 | $80.55 | $49K | 15,386 |
| 2022-02-07 | Cooke Julie Chief Human Resources Officer | Sale | −913 | $80.73 | $74K | 16,208 |
Page 55 of 62 · 1,221 trades